Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Eurofins BioPharma Product Testing Switzerland AG, Schonenwerd, Canada – FDA Inspections
Company
•Canada

Eurofins BioPharma Product Testing Switzerland AG, Schonenwerd, Canada – FDA Inspections

Inspection records and compliance data for Eurofins BioPharma Product Testing Switzerland AG in Schonenwerd. Access full analysis and detailed observations.

Sign in to open in Dashboard
Company Profile

This profile covers Eurofins BioPharma Product Testing Switzerland AG based in Schonenwerd, Canada.

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)
  • Health Canada · 1 inspection · last January 23, 2025
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Sartorius Stedim BioOutsource Limited
ITEST Plus, s.r.o.
CUP Laboratorien Dr. Freitag GmbH
Tepnel Pharma Services Limited
Charles River Laboratories Ireland Limited
Chelab S.R.L.
International Drug Development Xpert
Pathoquest
Laboratorio Medinfar - Produtos Famaceuticos, S.A
Novavax AB
Company Information

Name

Eurofins BioPharma Product Testing Switzerland AG

Address

Parkstrasse 10, Schonenwerd, 5012, Canada

Country

Canada

ID: ffca4acf-2a02-4e94-bad0-c473c4f2e307

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.